Munro, Michael P

Francis Morrison's practice includes the trial of intellectual property including pharmaceutical and electromagnetic matters, and products liability and other complex litigation matters, particularly those involving technical subjects. He has tried more than 55 cases to verdict and judgment in state and federal courts. He has represented institutional and corporate clients in connection with claims concerning patent and trade secret misappropriation, pharmaceuticals, aviation, tobacco, medical devices, insurance and manufacturing in high stakes litigation throughout the United States.

Mr. Morrison is a Fellow of the American College of Trial Lawyers (since 1993), a charter member of the American Board of Trial Advocates in Connecticut (since 1984), certified as a civil trial advocate by the National Board of Trial Advocacy (since 1986) and listed in Chambers USA, 2011 for Litigation as a "fantastic trial lawyer". Representative matters include:

Co-tried to conclusion (decision pending) for defendant Actavis the case of Pfizer Inc. et al. v. Teva Pharma et al. in the U.S. District Court for the District of Delaware. The case  involved the drug Lyrica and resulted in a nine day trial to the Court.

Lead trial counsel for Actavis/Purepac defendants in a jury trial in In Re Gabapentin Patent Litigation  in the U.S. District Court for the District of New Jersey.  The case concluded after two weeks of trial in a favorable settlement. 

Successfully co-tried opposition to Motion for Preliminary Injunction brought by plaintiff Covidien regarding launch of 7.5 mg generic Temazepam by URL Pharma in the U.S. District Court for the District of New Jersey.

Successfully First Chaired to judgment in the Southern District of New York claims of breach of contract and damages on behalf of plaintiff in a dispute between two international chemical concerns.

Led successful defense and favorable settlement of infringement claims involving medical devices employing alleged patented optical fiber technology.

Argued Summary Judgment Motion of Non-Infringement based on Prosecution Disclaimer for defendant generic manufacturer in Paragraph IV litigation concerning Adderall XR in the U.S. District Court for the District of Maryland.

Obtained Judgment of Dismissal for Purdue Pharma with respect to addiction and fraud claims allegedly arising out of use of Oxycontin and defendant's 2007 guilty plea to misbranding the same.

First Chaired TRO Hearing on behalf of plaintiff optical fiber manufacturer in Delaware Chancery Court in matter involving technical trade secrets leading to favorable settlement negotiations.

Defended to judgment claims of trade secret misappropriation involving Bristol Myers Squibb and Purdue Pharma concerning the launch of Oxycontin.

Argued appeal in the U.S. Court of Appeals for the Seventh Circuit for international chemical company in a matter involving billions of dollars of high technology commerce. Obtained reversal of District Court dismissal and reassignment of the case to a new presiding judge on remand.

Argued appeal in the U.S. Court of Appeals for the Second Circuit for The Northwestern Mutual Life Insurance Company and obtained an affirmance of District Court's award of summary judgment in Northwestern's favor.

Obtained summary judgment of validity and infringement for a patentee in the U.S. District Court for the Central District of California in a bet-the-company case involving electronic temperature monitors, and argued the ensuing appeal at the Federal Circuit.

Successfully co-tried to judgment Clearwater v. Evapco et al., a matter involving claims of trade secret misappropriation in the field of electromagnetic water treatment.

First Chaired Markman hearing in a case involving patent infringement and trade secret misappropriation claims against a hand tool manufacturer, resulting in dismissal with prejudice of all claims against the client.

Successfully tried to verdict patent infringement and invalidity claims on behalf of Nidec Corporation, involving direct current brushless fans used to cool electronic devices.

First Chaired trial to verdict for Brown and Williamson Tobacco Company in wrongful death claims related to the use of tobacco products.

Defended claims against jet engine manufacturer arising out of 2003 crash of a 737-200 aircraft in Algeria.

Defended claims of addiction against GlaxoSmithKline arising out of use of Paxil.

Mr. Morrison practiced for more than 30 years with the law firms of Day Pitney LLP and Day, Berry & Howard LLP, and served as the Chair of the Executive and Partnership Compensation Committees at Day, Berry & Howard LLP.